DRD2 is critical for pancreatic cancer and promises pharmacological therapy by already established antagonists

DRD2 对于胰腺癌至关重要，并有望通过已经建立的拮抗剂进行药物治疗

• 批准号: 352306
• 负责人: jandaghi Pouria
• 金额: $ 0.07万
• 依托单位: McGill University
• 依托单位国家: 加拿大
• 财政年份: 2016
• 资助国家: 加拿大
• 起止时间: 2016-07-01 至 2016-08-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=352306&lang=en
• 关键词: Cancer; Cell Biology; Drug Treatment

For pancreatic cancer, the rate of diagnosis is almost similar to the rate of mortality because in majority of patients, tumor is discovered in the late stages when it has spread throughout the pancreas. This aggressive behavior of pancreatic cancer gives

对于胰腺癌，诊断率几乎与死亡率相似，因为在大多数患者中，肿瘤是在晚期发现的，当时它已经扩散到整个胰腺。胰腺癌的这种侵略性行为